{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9a7c9df4db3d","filters":{"venue":"Indonesian Journal of Biomedicine and Clinical Sciences"}},"results":[{"id":"W4415371933","doi":"10.22146/inajbcs.v57i3.supplement.24251","title":"Effectiveness and safety of camrelizumab combined with pemetrexed-carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC): a systematic review and meta-analysis","year":2025,"lang":"","type":"review","venue":"Indonesian Journal of Biomedicine and Clinical Sciences","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Lung cancer; Pemetrexed; Adverse effect; Jadad scale; Hazard ratio; Chemotherapy; Survival rate; Immunotherapy","authors":[{"name":"Intan Dwikarlina","is_ca":false},{"name":"Genta Antariksa","is_ca":false},{"name":"Brenda Kristi","is_ca":false},{"name":"Masaaki Hamada","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02778981532177763,"gpt":0.4037758252972134,"spread":0.3759860099754357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009465989,0.002461794,0.01923192,0.005131109,0.0005568924,0.003006755,0.002069603,0.002204268,0.002998407],"category_scores_gemma":[0.01867642,0.001318699,0.03466793,0.005814839,0.0006636543,0.001746271,0.001312745,0.001531217,0.0003240454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002545331,"about_ca_system_score_gemma":0.003333701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005687525,"about_ca_topic_score_gemma":0.01384321,"domain_scores_codex":[0.9939321,0.002654435,0.001940815,0.0006112664,0.0006647622,0.000196692],"domain_scores_gemma":[0.9919292,0.005445388,0.001473265,0.0002609559,0.0007342508,0.000157058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001687025,0.00003579775,0.001721884,0.5066558,0.4791951,0.0001069814,0.00009096212,0.0004631873,0.0002525452,0.0001155979,0.0004121603,0.009262929],"study_design_scores_gemma":[0.0005319408,0.0002296512,0.002091759,0.0273973,0.9678184,0.00008116959,0.00004339266,0.000161804,0.0001042247,0.000128315,0.001388609,0.00002338917],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005357521,0.9930775,0.0003450208,0.0001380204,0.0001050963,0.0003241851,0.0003926083,0.00001974073,0.0002403732],"genre_scores_gemma":[0.1666728,0.8271092,0.002004032,0.001053693,0.000226054,0.00151034,0.0008766809,0.00003423715,0.0005129628],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01923192,"threshold_uncertainty_score":0.05006152,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}